KNSA - Kiniksa Pharmaceuticals, Ltd.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5729.21M
Enterprise Value 3420.52M
Trailing P/E N/A
Forward P/E 1-3.58
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.38
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-2.65

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3-12.44%
S&P500 52-Week Change 35.54%
52 Week High 332.88
52 Week Low 313.04
50-Day Moving Average 314.12
200-Day Moving Average 316.90

Share Statistics

Avg Vol (3 month) 398.31k
Avg Vol (10 day) 361.2k
Shares Outstanding 519.01M
Float 11.34M
% Held by Insiders 18.38%
% Held by Institutions 174.05%
Shares Short (Jun 28, 2019) 4969.01k
Short Ratio (Jun 28, 2019) 47.69
Short % of Float (Jun 28, 2019) 47.02%
Short % of Shares Outstanding (Jun 28, 2019) 41.77%
Shares Short (prior month May 31, 2019) 4993.28k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-34.91%
Return on Equity (ttm)-59.79%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -158.72M
Net Income Avi to Common (ttm)-153.07M
Diluted EPS (ttm)-3.66
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)326.53M
Total Cash Per Share (mrq)5.97
Total Debt (mrq)3.62M
Total Debt/Equity (mrq)1.18
Current Ratio (mrq)9.08
Book Value Per Share (mrq)5.60

Cash Flow Statement

Operating Cash Flow (ttm)-129.3M
Levered Free Cash Flow (ttm)-88.5M